These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 10729911

  • 1. Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis.
    Petry KG, Boullerne AI, Pousset F, Brochet B, Caillé JM, Dousset V.
    Pathol Biol (Paris); 2000 Feb; 48(1):47-53. PubMed ID: 10729911
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.
    Stuerzebecher S, Martin R.
    Neuroimaging Clin N Am; 2000 Nov; 10(4):649-68 ,vii-viii. PubMed ID: 11359717
    [Abstract] [Full Text] [Related]

  • 6. Early MRI changes in a mouse model of multiple sclerosis are predictive of severe inflammatory tissue damage.
    Nessler S, Boretius S, Stadelmann C, Bittner A, Merkler D, Hartung HP, Michaelis T, Brück W, Frahm J, Sommer N, Hemmer B.
    Brain; 2007 Aug; 130(Pt 8):2186-98. PubMed ID: 17617655
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pathological findings in rats with experimental allergic encephalomyelitis.
    Dong M, Liu R, Guo L, Li C, Tan G.
    APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis.
    Shaw CM, Alvord EC.
    Prog Clin Biol Res; 1984 Nov; 146():61-6. PubMed ID: 6201924
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS, Wu ZY, Zhang HP, Furtado G, Chen X, Yan SF, Schmidt AM, Brown C, Stern A, LaFaille J, Chess L, Stern DM, Jiang H.
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [Abstract] [Full Text] [Related]

  • 16. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L, Zamvil SS.
    Trends Immunol; 2005 Nov; 26(11):565-71. PubMed ID: 16153891
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of stem cells for the treatment of multiple sclerosis.
    Karussis D, Kassis I.
    Expert Rev Neurother; 2007 Sep; 7(9):1189-201. PubMed ID: 17868017
    [Abstract] [Full Text] [Related]

  • 19. Passive induction of experimental allergic encephalomyelitis.
    Stromnes IM, Goverman JM.
    Nat Protoc; 2006 Sep; 1(4):1952-60. PubMed ID: 17487182
    [Abstract] [Full Text] [Related]

  • 20. EAE: imperfect but useful models of multiple sclerosis.
    't Hart BA, Gran B, Weissert R.
    Trends Mol Med; 2011 Mar; 17(3):119-25. PubMed ID: 21251877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.